Managing inadequate response to initial anti-TNF therapy in rheumatoid arthritis: optimising treatment outcomes.

Taylor, Peter C; Matucci Cerinic, Marco; Alten, Rieke; Avouac, Jérôme; Westhovens, Rene

Taylor, Peter C; Matucci Cerinic, Marco; Alten, Rieke; Avouac, Jérôme; Westhovens, Rene.

Afiliação

Taylor PC; Botnar Research Centre, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Old Rd, Headington, Oxford OX3 7LD, UK.
Matucci Cerinic M; Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy.
Alten R; Department of Internal Medicine, Rheumatology, Clinical Immunology and Osteology, Schlosspark-Klinik University Medicine Berlin, Berlin, Germany.
Avouac J; AP-HP Centre, Université de Paris, Hôpital Cochin, Service de Rhumatologie, Paris, France.
Westhovens R; Skeletal Biology and Engineering Research Center, Department of Development and Regeneration and Division of Rheumatology, KU Leuven, Leuven, Belgium.

Ther Adv Musculoskelet Dis ; 14: 1759720X221114101, 2022.

Article em En | MEDLINE | ID: mdl-35991524

Palavras-chave

anti-TNFs; biologics; inadequate response; rheumatoid arthritis

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Temas: Geral Base de dados: MEDLINE Tipo de estudo: Guideline / Prognostic_studies Idioma: En Revista: Ther Adv Musculoskelet Dis Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Reino Unido

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google